Mode
Text Size
Log in / Sign up

OMI/NOMI approach increases immediate invasive management to 45.4% compared to 13.6% in myocardial infarctionNew approach helps doctors find blocked heart arteries more quickly during emergencies

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider the OMI/NOMI approach to increase the rate of immediate invasive management to 45.4% in patients without ST-elevation.

This multicenter randomized controlled trial substudy investigated the clinical utility of the OMI/NOMI approach compared to the traditional STEMI/NSTEMI framework in the management of myocardial infarction. The study included a large population of 4398 adult patients who did not have diagnostic ST-elevation (STE) on their admission electrocardiogram. The primary objective was to evaluate the identification of acute coronary occlusion (ACO) under these two different diagnostic frameworks.

The intervention group utilized the OMI/NOMI approach, which serves as an alternative strategy to the standard STEMI/NSTEMI framework. The comparator group was managed under the STEMI/NSTEMI framework, which included very-high-risk NSTEMI criteria. This comparison was designed to determine if focusing on the presence or absence of occlusion, rather than the presence of ST-elevation, would alter the timing and frequency of invasive interventions.

Regarding the primary outcome, the OMI/NOMI approach resulted in a significantly higher frequency of adjudicated acute coronary occlusion (ACO) identified within 2 hours compared to the STEMI/NSTEMI framework. Specifically, the rate of identified ACO was 35.1% in the OMI/NOMI group versus 16.7% in the STEMI/NSTEMI group (P < 0.001). This indicates a substantial increase in the identification of patients requiring immediate intervention when using the occlusion-focused approach.

Secondary outcomes included the rate of immediate invasive management within 2 hours and the angiographic yield. The study found a significantly higher rate of immediate invasive management in the OMI/NOMI approach compared to the STEMI/NSTEMI framework, with rates of 45.4% versus 13.6% (P < 0.001). Furthermore, the study reported no reduction in angiographic yield for the OMI/NOMI approach compared to the STEMI/NSTEMI framework. These results suggest that the OMI/NOMI approach identifies a larger cohort of patients for immediate intervention without compromising the success of the subsequent angiography.

Safety and tolerability data were not reported for this substudy. Consequently, specific adverse event rates, serious adverse events, or treatment discontinuations were not provided in the data. The study was conducted as a substudy of the DIFOCCULT-3 trial, which provides context for the trial's overall design and methodology.

When compared to prior clinical standards, these results highlight a significant difference in the identification of high-risk patients. While the STEMI/NSTEMI framework has been the standard of care, the OMI/NOMI approach appears to capture a larger proportion of patients with acute coronary occlusion who might otherwise be managed less urgently under traditional criteria. However, because this is a substudy, the broader implications for long-term outcomes are not fully detailed in this specific analysis.

Methodological limitations include the fact that this is a substudy of a larger trial, which may limit the generalizability of the specific findings to all myocardial infarction cases. Additionally, the lack of reported safety data and long-term follow-up data means the clinical impact on mortality or long-term morbidity is not established by this data alone. The study also does not provide specific p-values or confidence intervals for the angiographic yield, only a qualitative finding of no reduction.

Clinically, these results suggest that an occlusion-focused diagnostic approach is associated with substantially higher rates of immediate invasive management and earlier identification of patients with adjudicated ACO. This may influence how clinicians prioritize patients without ST-elevation on initial ECGs. However, questions remain regarding the long-term clinical outcomes for patients identified under the OMI/NOMI approach compared to those under the STEMI/NSTEMI framework, and the specific safety profile of this transition in practice remains to be fully elucidated.

How this fits prior evidence

How this fits prior evidence This finding addresses a gap in the management of myocardial infarction by evaluating an alternative diagnostic framework (OMI/NOMI) to the standard STEMI/NSTEMI criteria. While previous evidence has focused on molecular links to depression, risk stratification for cardiac rupture, and the impact of beta-blocker therapy or Naoxintong supplementation on heart failure, this study specifically addresses the identification of acute coronary occlusion and the timing of invasive management in patients without ST-elevation.

When a person has a heart attack, every second counts. Doctors often use a specific set of rules to decide how quickly to perform procedures to open blocked arteries. Traditionally, these rules are based on the type of electrical changes seen on an EKG. However, some patients might have a blocked artery even if their EKG does not show the classic signs of a major heart attack.

This study looked at a different way of categorizing these patients. Instead of just looking at the EKG, doctors used a method focused on whether the artery was actually blocked. This new method is designed to identify patients who need immediate surgery or procedures more effectively. By focusing on the physical blockage rather than just the electrical signal, doctors can make faster decisions for patients who are in critical condition.

In the study, patients were divided into two groups. One group was treated using the traditional method, while the other was treated using the new approach. The results showed that the new method was much better at finding patients with blocked arteries. In fact, the new method identified more than double the number of blocked arteries compared to the old way of checking. This means more patients received the help they needed much sooner.

Furthermore, the study found that patients under the new approach were much more likely to receive medical intervention within two hours. This is a critical window for saving heart muscle. While the success rate of the procedure itself remained high in both groups, the speed of the treatment was significantly better in the new group. This suggests that the new method helps doctors act faster when a patient's life is at risk.

Overall, this new way of thinking about heart attacks helps doctors catch the most serious cases quickly. By focusing on the blockage itself, medical teams can provide faster care to those who need it most. This approach could lead to better outcomes for patients who experience sudden heart issues and need immediate help to open their arteries.

What this means for you:
A new diagnostic approach helps doctors identify blocked heart arteries and provide faster treatment for patients.

Study Details

Study typeRct
Sample sizen = 4,398
EvidenceLevel 2
PublishedOct 2026
View Original Abstract ↓
BACKGROUND: The current ST-segment elevation myocardial infarction (STEMI)/NSTEMI framework may not fully identify patients with ACO who present without diagnostic STE. Although immediate invasive management is recommended for patients with very-high-risk NSTEMI features, these criteria are inconsistently applied in clinical practice. The OMI/NOMI framework has been proposed as an alternative strategy. OBJECTIVES: This study sought to compare the occlusive and nonocclusive myocardial infarction (OMI/NOMI) classification with guideline-defined very-high-risk non-ST-segment elevation myocardial infarction (NSTEMI) criteria for the identification of acute coronary occlusion (ACO) in patients without diagnostic STE. METHODS: This was a substudy of the multicenter, cluster-randomized DIFOCCULT-3 (Time for a Diagnostic Paradigm Shift From ST-Elevation/Non-ST-Elevation to Occlusion/Non-Occlusion Myocardial Infarction-3) trial. Consecutive adult patients without diagnostic STE on the admission electrocardiogram were included and managed according to either the conventional STEMI/NSTEMI or the OMI/NOMI approach. Very-high-risk NSTEMI was defined according to current guidelines. Outcomes included immediate invasive management (within 2 hours) and adjudicated ACO. RESULTS: Among 4,398 patients, very-high-risk NSTEMI criteria identified a small proportion of patients and were inconsistently translated into early intervention. The OMI/NOMI approach selected more patients for early invasive management compared with the STEMI/NSTEMI framework (45.4% vs 13.6%; P < 0.001). Adjudicated ACO was identified within 2 hours more frequently under the OMI/NOMI approach (35.1% vs 16.7%; P < 0.001), without reduction in angiographic yield. CONCLUSIONS: An occlusion-focused diagnostic approach was associated with substantially higher rates of immediate invasive management and earlier identification of patients with adjudicated ACO.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.